[Federal Register Volume 59, Number 66 (Wednesday, April 6, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-8184]
[[Page Unknown]]
[Federal Register: April 6, 1994]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Health Care Policy and Research
Assessment of Medical Technology
The Agency for Health Care Policy and Research (AHCPR), through its
Office of Health Technology Assessment (OHTA), announces that it is
initiating a Technology Assessment or a Technology Review (see below)
of the safety, clinical effectiveness and indications for the use of
signal-averaged electrocardiography (SAECG). This technique reduces the
level of background noise that is present in the standard
electrocardiography and allows the detection of signals of very low
amplitude, such as ventricular late potentials. The AHCPR is
particularly interested in whether the performance of SAECG has a
positive effect on health outcomes and whether it influences the
medical management of the patient.
A description of AHCPR's process for conducting technology
assessments and technology reviews was published in the Federal
Register, December 3, 1993. In brief, the full assessment process
includes an extensive review of the published literature, consultation
with other components of the Public Health Service (PHS), obtaining
information from relevant specialty groups and evaluation of
information received in response to a Federal Register notice. A
technology review is a shorter evaluation of a technology; it may be
performed if the medical or scientific questions posed are limited, the
available evidence is limited and the published medical literature is
insufficient in quantity or quality, or the time frame available
precludes utilization of the full assessment process.
The AHCPR is interested in receiving information which would help
in the assessment or review of the technology as described above. To
enable the scientific community to evaluate the information included in
the assessment or review, AHCPR will discuss in the assessment or
review only those data and analyses for which a source(s) may be cited.
Respondents are therefore encouraged to include with their submissions
a written consent permitting AHCPR to cite the sources of the data and
comments provided. Otherwise, in accordance with the confidentiality
statute governing information collected by AHCPR, 42 U.S.C. 299a-l(c),
no information received will be published or disclosed which could
identify an individual or entity described in the information, or could
identify an entity or individual supplying the information.
Information and comments should be submitted in writing no later
than July 5, 1994 to the AHCPR Office of Health Technology Assessment
at the address below.
Thomas V. Holohan, M.D., Director, Office of Health Technology
Assessment, AHCPR, 6000 Executive Boulevard, suite 309, Rockville, MD
20852, Phone: (301) 594-4023.
Dated: March 30, 1994.
J. Jarrett Clinton,
Administrator.
[FR Doc. 94-8184 Filed 4-5-94; 8:45 am]
BILLING CODE 4160-90-P
